RxDoctor Payments Data

Keanan Dowell

Hematology & Oncology · Ft Worth, TXNPI 1730745167

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,350 of the $1,617 with a category attached, or 83.5%. It is spread thinly across 23 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in TX, where the typical reported total is $3,204.

$1,617in general payments, 2019–2025

Across 57 payments — averaging $28.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$365
  • Pfizer$280
  • Johnson & Johnson$145
  • Sanofi$128
  • Daiichi Sankyo Inc.$74
  • AstraZeneca$71
  • plus $554 from 17 others

What the payments were for

  • Food & beverage$1,35083%
  • Education$26717%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,617 in reported general payments places this provider in the 35th percentile of 838 hematology & oncology providers in Texas.

See all hematology & oncology providers in Texas →

Other hematology & oncology in Ft Worth

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →